Show simple item record

dc.contributor.authorKosmin, M
dc.contributor.authorMakris, A
dc.contributor.authorJoshi, P
dc.contributor.authorAh-See, M
dc.contributor.authorWoolf, David K
dc.contributor.authorPadhani, A
dc.date.accessioned2017-06-29T10:44:26Z
dc.date.available2017-06-29T10:44:26Z
dc.date.issued2017-05
dc.identifier.citationThe addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer. 2017, 77:109-116 Eur J Canceren
dc.identifier.issn1879-0852
dc.identifier.pmid28390297
dc.identifier.doi10.1016/j.ejca.2017.03.001
dc.identifier.urihttp://hdl.handle.net/10541/620432
dc.description.abstractAccurate evaluation of distribution of disease and response to systemic anti-cancer therapy (SACT) is important in the optimal management of metastatic breast cancer. Whole-body magnetic resonance imaging (WB-MRI) has increased accuracy over computerised tomography of the chest, abdomen and pelvis (CT-CAP) for detecting liver and bone disease, but its effect on patient management is largely unexplored. This study investigates the effects of using WB-MRI alongside CT-CAP on SACT decisions in standard clinical practice for patients with metastatic breast cancer.
dc.language.isoenen
dc.rightsArchived with thanks to European journal of cancer (Oxford, England : 1990)en
dc.titleThe addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer.en
dc.typeArticleen
dc.contributor.departmentBreast Cancer Research Unit, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex HA6 2RN, UK.en
dc.identifier.journalEuropean Journal of Canceren
html.description.abstractAccurate evaluation of distribution of disease and response to systemic anti-cancer therapy (SACT) is important in the optimal management of metastatic breast cancer. Whole-body magnetic resonance imaging (WB-MRI) has increased accuracy over computerised tomography of the chest, abdomen and pelvis (CT-CAP) for detecting liver and bone disease, but its effect on patient management is largely unexplored. This study investigates the effects of using WB-MRI alongside CT-CAP on SACT decisions in standard clinical practice for patients with metastatic breast cancer.


Files in this item

This item appears in the following Collection(s)

Show simple item record